×
About 1,450 results

ALLMedicine™ Salpingectomy Center

Research & Reviews  484 results

Gestational trophoblastic neoplasm in a patient with end-stage renal failure (ESRF): th...
https://doi.org/10.1136/bcr-2022-249474
BMJ Case Reports; Loo KCY, Lim YN et. al.

May 19th, 2022 - Gestational trophoblastic neoplasm (GTN) in end-stage renal failure (ESRF) has not been reported. We reported an unprecedented case of GTN in ESRF from an antecedent partial mole. She had total abdominal hysterectomy and bilateral salpingectomy fo...

Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.
https://doi.org/10.3802/jgo.2022.33.e51
Journal of Gynecologic Oncology; do Valle HA, Kaur P et. al.

May 14th, 2022 - Examine the risks of fractures and osteoporosis after risk-reducing bilateral salpingo-oophorectomy (RRBSO) among women with BRCA1/2 mutations. In this retrospective population-based study in British Columbia, Canada, between 1996 to 2017, we comp...

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
https://clinicaltrials.gov/ct2/show/NCT05287451

May 11th, 2022 - The aim of the project is to evaluate RRS with delayed RRO as an alternative for RRSO in BRCA1/2 gene germline mutation carriers with respect to ovarian cancer incidence. We hypothesize that postponement of oophorectomy and consequent menopause to...

ASA in Prevention of Ovarian Cancer (STICs and STONEs)
https://clinicaltrials.gov/ct2/show/NCT03480776

May 10th, 2022 - The standard or usual treatment for women with a high risk gene mutation, BRCA1 or BRCA2, is to have risk-reducing surgery to remove the fallopian tubes and ovaries (bilateral salpingo-oophorectomy or bilateral salpingectomy inclusive of fimbria) ...

Prior salpingectomy impairs the retrieved oocyte number in in vitro fertilization cycle...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067640
PloS One; Ho CY, Chang YY et. al.

May 5th, 2022 - The impairment of the ovarian response in in vitro fertilization (IVF) cycles after salpingectomy remains contentious. Therefore, we investigated whether a history of salpingectomy affects the number of oocytes retrieved in women undergoing IVF in...

see more →

Guidelines  3 results

Guideline No. 414: Management of Pregnancy of Unknown Location and Tubal and Nontubal E...
https://doi.org/10.1016/j.jogc.2021.01.002
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Po L, Thomas J et. al.

Jan 17th, 2021 - To provide an evidence-based algorithm to guide the diagnosis and management of pregnancy of unknown location and tubal and nontubal ectopic pregnancy. All patients of reproductive age. The implementation of this guideline aims to benefit patients...

No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fal...
https://doi.org/10.1016/j.jogc.2016.12.005
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Salvador S, Scott S et. al.

May 22nd, 2017 - This guideline reviews the potential benefits of opportunistic salpingectomy to prevent the development of high grade serous cancers (HGSC) of the ovary/fallopian tube/peritoneum based on current evidence supporting the fallopian tube origin of di...

Committee Opinion No. 685: Care for Transgender Adolescents.
https://doi.org/10.1097/AOG.0000000000001861
Obstetrics and Gynecology;

Dec 22nd, 2016 - Gender nonconforming youth are an underserved population who obstetrician-gynecologists are seeing increasingly in their practices. Currently, there are large gaps in training, knowledge, and comfort with transgender patients among obstetrician-gy...

see more →

Clinicaltrials.gov  26 results

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
https://clinicaltrials.gov/ct2/show/NCT05287451

May 11th, 2022 - The aim of the project is to evaluate RRS with delayed RRO as an alternative for RRSO in BRCA1/2 gene germline mutation carriers with respect to ovarian cancer incidence. We hypothesize that postponement of oophorectomy and consequent menopause to...

ASA in Prevention of Ovarian Cancer (STICs and STONEs)
https://clinicaltrials.gov/ct2/show/NCT03480776

May 10th, 2022 - The standard or usual treatment for women with a high risk gene mutation, BRCA1 or BRCA2, is to have risk-reducing surgery to remove the fallopian tubes and ovaries (bilateral salpingo-oophorectomy or bilateral salpingectomy inclusive of fimbria) ...

A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
https://clinicaltrials.gov/ct2/show/NCT04251052

Apr 15th, 2022 - PRIMARY OBJECTIVE: I. To compare the non-inferiority of bilateral salpingectomy (BLS) with delayed oophorectomy to bilateral salpingo-oophorectomy (BSO) to reduce the risk of ovarian cancer among women with deleterious BRCA1 germline mutations. SE...

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
https://clinicaltrials.gov/ct2/show/NCT04831580

Apr 14th, 2022 - This is a multi-center, open-label, randomized, non-inferiority clinical trial with the hypothesis that robotically assisted radical hysterectomy with tumor containment prior to colpotomy is non-inferior to abdominal radical hysterectomy with resp...

Comparison Between 2 Techniques for Bilateral Salpingectomy
https://clinicaltrials.gov/ct2/show/NCT03788421

Mar 10th, 2022 - Ovarian cancer is the most lethal gynecologic malignancy. Major contributors to this high mortality are the lack of effective screening strategies, diagnosis at advanced stage of presentation as well as the high risk of recurrence. In the last yea...

see more →

News  67 results

Removing Fallopian Tubes During Hysterectomy May Curb Ovarian Cancer Risk
https://www.medscape.com/viewarticle/968752

Feb 22nd, 2022 - NEW YORK (Reuters Health) - Removal of the fallopian tubes during hysterectomy or instead of tubal ligation, a procedure known as opportunistic salpingectomy (OS), was associated with fewer serous and epithelial ovarian cancers than expected in a ...

Support for Gene-Specific Risk-Reduction Strategies in Lynch Syndrome
https://www.medscape.com/viewarticle/958614

Sep 14th, 2021 - NEW YORK (Reuters Health) - New research supports adoption of a gene-specific approach to risk-reduction strategies for gynecologic cancers in women with Lynch Syndrome, finding such an approach to be cost-effective and associated with improved qu...

Lawsuit: Misplaced Test Result Leads to Unneeded Surgery
https://www.medscape.com/viewarticle/950547

May 10th, 2021 - Errors are inevitable, which is why good systems have built-in processes that require double-checking activities and results. But when the "double-check" gets overlooked, all of that effort can come to naught. A woman in her mid-40s with a history...

Ovarian Cancer Prevention: How Patients Decide on Surgery
https://www.medscape.com/viewarticle/946953

Mar 5th, 2021 - Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small study. Investigators interviewed 24 premenopausal women with BRCA mutations who were ...

Ovarian cancer prevention: How patients decide on surgery
https://www.mdedge.com/hematology-oncology/article/236723/gynecologic-cancer/ovarian-cancer-prevention-how-patients-decide
M. Alexander Otto

Mar 4th, 2021 - Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small study. Investigators interviewed 24 premenopausal women with BRCA mutations who were.

see more →